BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• Business

  Poseida Therapeutics Provides Updates and Financial Results for the Second Quarter of 2024

  August 5, 2024

   · 

  13 min read
• Business

  Azenta to Participate in 9th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference

  August 5, 2024

   · 

  1 min read
• Business

  BioMarin Announces Updated Strategy for ROCTAVIAN® to Focus on U.S., Germany and Italy

  August 5, 2024

   · 

  6 min read
• Business

  BioMarin Announces 20% Y/Y Total Revenue Growth in the Second Quarter and Increase in Full-year 2024 Guidance

  August 5, 2024

   · 

  27 min read
• Press Releases

  Relief Therapeutics Secures up to $11 Million from Royalty Sales

  August 5, 2024

   · 

  4 min read
• Press Releases

  Apotex expands ophthalmic franchise through the acquisition of Canadian rights to APP13007 (clobetasol propionate ophthalmic suspension, 0.05%), a novel steroid for ophthalmology

  August 5, 2024

   · 

  2 min read
• Press Releases

  Genmab Takes Full Control of Acasunlimab Development Program

  August 5, 2024

   · 

  5 min read
• Press Releases

  BioNTech Announces Second Quarter 2024 Financial Results and Corporate Update

  August 5, 2024

   · 

  36 min read
• Press Releases

  BioCryst Reports Second Quarter 2024 Financial Results and Provides Business Update

  August 5, 2024

   · 

  15 min read
• Press Releases

  InspireMD Congratulates CREST-2 Investigators on Completion of Trial Enrollment

  August 5, 2024

   · 

  6 min read